JHP Pharmaceuticals LLC: Clinical Trials

3 unknown. 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	3	Unknown 3

Follow JHP Pharmaceuticals LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2) To compare new PPD to reference standard material, Reference standard - Tuberculosis Identification.	Phase 2	Unknown	JHP Pharmaceuticals LLC	90	2013-02-01	2013-02-25
Equivalence Study of Specificity of PPD Aplisol@ PPD material, Reference Standard - Tuberculosis Infection	Phase 2	Unknown	JHP Pharmaceuticals LLC	152	2013-02-01	2013-02-25
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose) To confirm the potency of Aplisol formulated with newly produced Tuberculin PPD compared to PPD-S2 standard., Reactivity of Aplisol compared to reference standard PPD-S2. - Tuberculosis Infection	Phase 2	Unknown	JHP Pharmaceuticals LLC	168	2012-05-01	2012-09-21

Conditions studied

Latent Tuberculosis (2)  ·  Tuberculosis (1)

Interventions

Reference Standards (2)  ·  Tuberculin (2)

Countries

United States (2)